A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
NCT05214768
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Eosinophilic Gastroenteritis
Interventions
DRUG:
CC-93538
DRUG:
Placebo
Sponsor
Celgene